172,909 Shares in Sharps Technology, Inc. (NASDAQ:STSS) Purchased by Garden State Investment Advisory Services LLC

Garden State Investment Advisory Services LLC purchased a new stake in Sharps Technology, Inc. (NASDAQ:STSSFree Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 172,909 shares of the company’s stock, valued at approximately $26,000. Garden State Investment Advisory Services LLC owned 9.61% of Sharps Technology as of its most recent filing with the SEC.

Sharps Technology Stock Performance

Sharps Technology stock opened at $2.04 on Friday. Sharps Technology, Inc. has a 52-week low of $1.70 and a 52-week high of $18.15. The business’s 50 day simple moving average is $2.83. The firm has a market cap of $3.67 million, a price-to-earnings ratio of -0.25 and a beta of 1.37.

Sharps Technology Company Profile

(Free Report)

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.

Featured Articles

Want to see what other hedge funds are holding STSS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sharps Technology, Inc. (NASDAQ:STSSFree Report).

Receive News & Ratings for Sharps Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Technology and related companies with MarketBeat.com's FREE daily email newsletter.